Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DR Protein (HLA-DR) (AA 26-216) (His tag)

HLA-DR Spezies: Human Wirt: Escherichia coli (E. coli) Recombinant Greater than 95 % as determined by SDS-PAGE ELISA, WB
Produktnummer ABIN7123353
  • Target Alle HLA-DR Produkte
    HLA-DR
    Protein-Typ
    Recombinant
    Proteineigenschaft
    AA 26-216
    Spezies
    Human
    Quelle
    Escherichia coli (E. coli)
    Aufreinigungstag / Konjugat
    Dieses HLA-DR Protein ist gelabelt mit His tag.
    Applikation
    ELISA, Western Blotting (WB)
    Reinheit
    Greater than 95 % as determined by SDS-PAGE
    Sterilität
    0.2 μm filtered
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Haltbarkeit
    12 months
  • Target
    HLA-DR
    Andere Bezeichnung
    HLA-DR (HLA-DR Produkte)
    Hintergrund
    DASS-397D15.1, DR alpha chain, DR alpha chain precursor, DRA_HUMAN, DRB1, DRB4, FLJ51114, Histocompatibility antigen HLA DR alpha, Histocompatibility antigen HLA-DR alpha, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DR1B, HLA DR3B
    Molekulargewicht
    20.9 kDa
    UniProt
    P01903
Sie sind hier: